Characterisation of inosine monophosphate dehydrogenase expression during retinal development: differences between variants and isoforms
about
IMP dehydrogenase: structure, mechanism, and inhibition.IMP dehydrogenase type 1 associates with polyribosomes translating rhodopsin mRNAA regulatory role of the Bateman domain of IMP dehydrogenase in adenylate nucleotide biosynthesisAnti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapyDifferent characteristics and nucleotide binding properties of inosine monophosphate dehydrogenase (IMPDH) isoformsLoukoumasomes Are Distinct Subcellular Structures from Rods and Rings and Are Structurally Associated with MAP2 and the Nuclear Envelope in Retinal CellsNeural crest requires Impdh2 for development of the enteric nervous system, great vessels, and craniofacial skeletonAnti-rods/rings: a human model of drug-induced autoantibody generation.Quantitative analysis of purine nucleotides indicates that purinosomes increase de novo purine biosynthesis.Metabolic regulation via enzyme filamentationAnti-rods/rings autoantibody seropositivity does not affect response to telaprevir treatment for chronic hepatitis C infection.The dynamic determinants of reaction specificity in the IMPDH/GMPR family of (β/α)(8) barrel enzymes.Spatial Organization of Metabolic Enzyme Complexes in Cells.Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy.Ultrastructure of cytoplasmic and nuclear inosine-5'-monophosphate dehydrogenase 2 "rods and rings" inclusions.Glutamine deprivation initiates reversible assembly of mammalian rods and rings.Reconstituted IMPDH polymers accommodate both catalytically active and inactive conformations.Interfilament interaction between IMPDH and CTPS cytoophidia
P2860
Q24642299-7A74EF38-98D1-461F-9B30-1F7F613893FBQ24643480-9AE34E09-CABC-4A69-B7C6-2C00FF9EA3E0Q24655404-118E27D6-B0E9-4807-B5B1-6FCE303E4D02Q26766115-3E52DBB3-C0F2-46E8-951D-76A75D09B9FCQ27332315-C60D79B2-9011-49EC-9197-C3E98E62A727Q28553081-E47BBFA3-B559-4677-8DCE-CC9CF18E4EBCQ28834482-12DFA881-4C91-4AEF-A934-3242A549D7F9Q35053443-C8928F86-C62F-4DB3-8DFE-93518D511812Q35172577-C3D51B4E-5F55-473B-86B3-17AE14167E0FQ37025025-AB1F28E6-135E-4A54-8137-874A4246AF41Q37413335-D754E60E-2C26-415A-A8D5-AC362BCA2C22Q37983899-3F8F89CD-D588-47DE-A6F9-F73FFBFA168EQ39350533-7C17FE26-6E2E-4A58-A8A2-21F3520682EAQ41148251-6F174071-C923-4545-9BD4-956467EF97ABQ42209097-1360F357-2F5A-41AC-8409-8D1D8F5A891CQ45265983-F451D6DF-8C5C-4FEB-BED3-C117FD2F5366Q47113122-378F215F-A1D1-4066-B980-FF4484DA0B04Q58693459-DBF7624C-178B-48DF-8FB8-AF1489FEA73D
P2860
Characterisation of inosine monophosphate dehydrogenase expression during retinal development: differences between variants and isoforms
description
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
im Januar 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2008/01/01)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/01/01)
@nl
наукова стаття, опублікована в січні 2008
@uk
مقالة علمية (نشرت عام 2008)
@ar
name
Characterisation of inosine mo ...... between variants and isoforms
@ast
Characterisation of inosine mo ...... between variants and isoforms
@en
Characterisation of inosine mo ...... between variants and isoforms
@nl
type
label
Characterisation of inosine mo ...... between variants and isoforms
@ast
Characterisation of inosine mo ...... between variants and isoforms
@en
Characterisation of inosine mo ...... between variants and isoforms
@nl
prefLabel
Characterisation of inosine mo ...... between variants and isoforms
@ast
Characterisation of inosine mo ...... between variants and isoforms
@en
Characterisation of inosine mo ...... between variants and isoforms
@nl
P2093
P50
P3181
P1476
Characterisation of inosine mo ...... between variants and isoforms
@en
P2093
Alun Jones
Edith M Gardiner
Elaine C Thomas
Leah Worton
Nadia Lengefeld
Sarah J Kruger
P304
P3181
P356
10.1016/J.BIOCEL.2007.12.018
P577
2008-01-18T00:00:00Z